Cargando…
Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
BACKGROUND: Rare, heterozygous germline mutations in the RAD51C gene have been found in breast and ovarian cancer families. In the Finnish population, we have identified two founder mutations in RAD51C that increase the risk of ovarian cancer but not breast cancer in the absence of ovarian cancer. R...
Autores principales: | Pelttari, Liisa M, Nurminen, Riikka, Gylfe, Alexandra, Aaltonen, Lauri A, Schleutker, Johanna, Nevanlinna, Heli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522023/ https://www.ncbi.nlm.nih.gov/pubmed/23176254 http://dx.doi.org/10.1186/1471-2407-12-552 |
Ejemplares similares
-
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015) -
Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
por: Nurmi, Anna, et al.
Publicado: (2019) -
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017) -
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017) -
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
por: Kuusisto, Kirsi M, et al.
Publicado: (2011)